UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or
15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 8, 2006
EDWARDS
LIFESCIENCES CORPORATION
(Exact name
of registrant as specified in its charter)
|
Delaware |
|
1-15525 |
|
36-4316614 |
|
(State or other jurisdiction |
|
(Commission |
|
(IRS Employer |
|
of incorporation) |
|
file number) |
|
Identification No.) |
|
|
|
|
|
|
|
One Edwards Way, Irvine, California |
|
92614 |
||
|
(Address of principal executive offices) |
|
(Zip Code) |
||
|
|
|
|
||
(949) 250-2500
Registrant’s telephone number, including area code
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-Commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On March 8, 2006, Edwards Lifesciences Corporation, a Delaware corporation, issued a press release announcing its reclassification of $14 million from 2005 operating cash flows. A copy of the press release is attached as Exhibit 99.1.
The information furnished under this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits
99.1 Press release, dated March 8, 2006, announcing Edwards Lifesciences’ reclassification of $14.0 million from 2005 operating cash flows.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: March 8, 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EDWARDS LIFESCIENCES CORPORATION |
|
|
|
|
|
|
|
|
|
By: |
/s/ Thomas M. Abate |
|
|
|
|
Thomas M. Abate |
|
|
|
|
Corporate Vice President, |
|
|
|
|
Chief Financial Officer and Treasurer |
3
Exhibit Index
|
Exhibit |
|
Description |
|
|
|
|
|
99.1 |
|
Press release, dated March 8, 2006, announcing Edwards Lifesciences’ reclassification of $14.0 million from 2005 operating cash flows. |
4